Caspase-dependent degradation of YTHDF2 governs the epitranscriptomic control of chemotherapy responsiveness by regulating m6A-mediated MYC translation

An article created on 2026-08-19 05:14:05

#	Наименование новости	Информативность	Дата публикации
1	Time to Sustained CEA Elevation From Start of First-Line Therapy Predicts Initial Treatment Efficacy and Clinical Outcomes in Lung Adenocarcinoma	17.69	20-08-2026
2	Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC	28.75	20-08-2026
3	The Role of LINC00261 in Pancreatic Cancer Progression: Implications for EMT and FOXA2 Regulation	25	20-08-2026
4	Stability of c-Myc protein differentiates Ras oncogene addiction and MAPK pathway dependency in Ras-mutant multiple myeloma	23.64	20-08-2026
5	Regulation of RAS-GTPase Activity by Oncofetal Chondroitin Sulfate (Chondroitin 4-Sulfate) and Arylsulfatase B	18.95	19-08-2026
6	miR-325-3p Facilitates Tumorigenesis and Acquired Pemigatinib Resistance in Intrahepatic Cholangiocarcinoma via Targeting ADH1B through Epithelial–Mesenchymal Transition and PI3K/AKT Signaling	20.74	20-08-2026
7	NLRP4–ER Stress–CCL5 axis as a translational target for NK cell-based immunotherapy in lung cancer	25	19-08-2026
8	Sex-Associated Plasma Cell-Free DNA Methylation Patterns in Indonesian Lung Cancer: An Exploratory Study	23.93	20-08-2026
9	Nuclear Morphology Tracks Molecular Class Unevenly Across Four Cancers	16.67	20-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 22.13. Источник: www.researchsquare.com.

Найдите то, что Вас интересует